Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Multiple Awardees, See Attachment for award details. White Oak WV USA

UEI: SLED_BE4BAD786C89F8B4

Multiple Awardees, See Attachment for award details. White Oak WV USA is a federal contractor, registered under UEI SLED_BE4BAD786C89F8B4. It has been awarded $71,253,310 across 1 federal contract. Primary work spans Scientific Research and Development Services. Top awarding agencies include FDA Office Of Acq Grant Svcs.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_BE4BAD786C89F8B4

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

FDA Office Of Acq Grant Svcs$71.3M100%

Awards by NAICS

5417 - Scientific Research and Development Services$71.3M100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in Multiple Awardees, See Attachment for award details. White Oak WV USA's top NAICS codes and agencies

Manuscript Development and Publication SupportThe contract titled Manuscript Development and Publication Support entails comprehensive assistance in preparing research manuscripts derived from a specific dataset, including drafting, editing, and the creation of figures and visual elements essential for publication. It also requires expert support in responding to peer review feedback, ensuring the scholarly work meets rigorous academic standards and effectively communicates findings. Additionally, the contractor must coordinate closely with the FDA to facilitate its internal review process and obtain formal concurrence prior to submission or publication, aligning all outputs with regulatory expectations and scientific integrity. This subcontract is issued under the NAICS code 541990 for other scientific and technical consulting services by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. The opportunity was posted on July 28, 2026, with a firm response deadline of August 7, 2026, at 2:00 PM. While no specific location is designated for performance, the work is tied to FDA review processes and requires close collaboration with federal stakeholders. The contract does not include a set-aside designation, allowing eligible entities to compete without specific socioeconomic restrictions.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Secure Data Delivery and FDA Cybersecurity ComplianceThe contract requires the preparation and secure delivery of a final dataset in either CSV or HDF5 format, accompanied by comprehensive metadata to ensure full traceability and usability. All data handling and transmission must comply with FDA cybersecurity standards, necessitating the use of approved secure transfer protocols to safeguard sensitive information throughout the process. The deliverable is intended for use within a regulated environment, emphasizing data integrity, confidentiality, and adherence to federal cybersecurity requirements. This is a subcontract issued under the NAICS code 518210 by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. The opportunity was posted on July 28, 2026, with a response deadline of August 7, 2026. No set-aside type is designated, and the place of performance and point of contact details are not specified, indicating flexibility in execution location. The solicitation is accessible via a SAM.gov portal link, and contractors must ensure full compliance with FDA cybersecurity guidelines when handling and transferring the data.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Dataset De-Identification and Compliance with Privacy StandardsThe contract requires the de-identification of physiological datasets to ensure full compliance with HIPAA and FDA privacy regulations, focusing on the removal of all identifiable protected health information while maintaining the data’s analytical utility for artificial intelligence and machine learning training purposes. The work must adhere to strict standards that preserve the scientific integrity of the datasets, allowing researchers and developers to use them effectively without exposing individuals’ sensitive health details. This includes applying validated de-identification techniques and documenting all processes to meet federal audit and compliance requirements. As a subcontract under the Department of Health and Human Services, specifically managed by the FDA Office of Acquisition and Grant Services, the contract is classified under NAICS code 518210, indicating its focus on data processing and hosting services. The solicitation was posted on July 28, 2026, with a response deadline of August 7, 2026, and the place of performance is not specified, allowing for flexibility in execution as long as regulatory benchmarks are met. The contractor must demonstrate expertise in health data privacy, AI/ML readiness, and federal compliance protocols, delivering datasets that are both legally secure and functionally robust for downstream computational analysis.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Data Annotation and Time-Synchronized Event LabelingThe contract requires precise annotation of physiological signals with accurate timestamps for events, postural changes, and protocol deviations, ensuring strict time alignment across all sensor modalities to maintain data integrity and coherence for analysis. The work demands high accuracy in labeling temporal events to support research or regulatory applications involving multi-sensor physiological data collection. The solicitation, titled Data Annotation and Time-Synchronized Event Labeling, is a subcontract issued under the NAICS code 541990 by the FDA Office Of Acq Grant Svcs within the Department of Health and Human Services. It was posted on July 28, 2026, with a response deadline of August 7, 2026, at 2:00 PM. There is no specified set-aside classification or detailed location for performance, and no point of contact is provided in the data. The opportunity is accessible through the SAM.gov platform.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Human Subject Data Collection Using Wearable SensorsThe contract seeks to recruit and enroll human subjects for the collection of high-quality physiological signals including ECG, PPG, blood pressure, skin temperature, and activity data using wearable sensors under strictly controlled environmental and procedural conditions. The goal is to generate reliable, standardized biometric data for research purposes, likely to support scientific validation, algorithm development, or regulatory evaluation. Enrollment must adhere to protocols ensuring data integrity, participant safety, and compliance with ethical standards for human subject research. This subcontract is issued by the FDA Office of Acquisition and Grant Services under the U.S. Department of Health and Human Services, with a NAICS code of 541990 indicating it falls under other scientific and technical consulting services. The solicitation was posted on July 28, 2026, with a firm deadline for responses set for August 7, 2026, at 2:00 PM. While specific location details are not provided, performance is expected to occur at designated sites that can maintain the necessary controlled conditions. The nature of the work requires qualified personnel capable of recruiting diverse participants, deploying biomedical sensors accurately, and managing data collection with precision and consistency.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Systematic Review and Synthesis of Cardiac Physiological Signal DatasetsThe contract entails a systematic review and synthesis of publicly available cardiac physiological signal datasets, specifically focusing on electrocardiogram ECG, photoplethysmogram PPG, and accelerometry data, with the goal of producing manuscript-ready text that comprehensively consolidates existing research findings. The work requires rigorous analysis of diverse datasets to identify patterns, limitations, gaps, and standardization challenges in cardiac signal acquisition and interpretation across studies, ensuring the final output is suitable for publication in peer-reviewed scientific journals. The scope demands expertise in signal processing, biomedical data analysis, and scientific writing to transform raw data summaries into a coherent, evidence-based narrative. This subcontract is issued under NAICS code 541690, classified as a scientific research and development activity, and is administered by the FDA Office of Acquisition Grant Services within the Department of Health and Human Services. The solicitation was posted on July 28, 2026, with a response deadline of August 7, 2026, at 2:00 PM. While no specific location is designated for performance, the work is expected to be conducted remotely or through virtual collaboration, with the deliverable centered on written documentation rather than physical or laboratory-based outputs. There is no set-aside classification indicated, and the contract does not include designated points of contact or detailed address information in its public listing.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Field Service Reporting and Documentation ManagementThe contract titled Field Service Reporting and Documentation Management requires the successful bidder to compile and submit comprehensive, audit-ready records including maintenance summaries, field service logs, and calibration documentation to the FDA Contracting Officer’s Representative, ensuring full compliance with federal quality and regulatory documentation standards. All submissions must be accurate, timely, and structured to support federal inspections and regulatory compliance, particularly within the context of FDA oversight. The work is classified as a subcontract under NAICS code 541611, indicating it falls under scientific and technical consulting services, and is tied to the Department of Health and Human Services through the FDA Office of Acquisition and Grant Services. The contract was posted on July 28, 2026, with a response deadline of August 4, 2026, and the place of performance is located in Jefferson, Arkansas, with a ZIP code of 72079. Although no specific location details for the agency office are provided, the work is expected to be executed with a focus on supporting federal facilities or operations under FDA jurisdiction. The contract does not specify a set-aside type or organizational requirements, but adherence to strict documentation protocols and audit readiness are central to the deliverables, requiring the contractor to maintain rigorous internal controls and traceability for all reported data.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Software Licensing and System Verification ServicesThe contract seeks a subcontractor to manage SafePoint software licenses and conduct regular system verifications to ensure data integrity, proper alarm functionality, and full compliance with FDA quality standards, particularly 21 CFR Part 11. This includes ongoing oversight of license usage, system performance monitoring, and validation activities necessary to maintain regulatory alignment in a controlled environment. The work is focused on ensuring the software remains operationally reliable and audit-ready at all times. The solicitation is classified as a subcontract under NAICS code 511210, issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. Responses are due by August 4, 2026, and the place of performance is Jefferson, Arkansas, with a zip code of 72079. The contract was posted on July 28, 2026, and all activities must align with federal pharmaceutical and data quality requirements, emphasizing rigorous documentation, audit trails, and system controls to support compliance.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

24/7 Technical Support and Help Desk ServicesThe contract is for 24/7 technical support and help desk services, requiring continuous monitoring and rapid response to system alerts, connectivity failures, and emergency incidents under strict service level agreements with defined response and resolution times and formal escalation protocols. The work must be performed at a location in Jefferson, Arkansas, with performance expected to meet stringent operational standards for system reliability and incident management. The solicitation was posted on July 28, 2026, with a response deadline of August 4, 2026, and is classified as a subcontract under NAICS code 541512 for computer systems design services. The awarding agency is the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, with no set-aside designation specified. The contract does not include a designated point of contact, and all submissions must be made through the official SAM.gov portal.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Preventive Maintenance and On-Site Field ServiceThe contract outlines a requirement for scheduled preventive maintenance services on the SafePoint wireless monitoring system at the Arkansas laboratory located in Jefferson, with a zip code of 72079. The scope of work includes comprehensive inspections, firmware updates, battery replacements, and diagnostic evaluations to ensure the system’s continued operational reliability. All services must be performed on-site at the designated laboratory location, and the contractor is expected to adhere to established maintenance protocols and timelines. This is a subcontract under the FDA Office of Acquisition and Grant Services, part of the Department of Health and Human Services, with a NAICS code of 811211 indicating repair and maintenance services. The solicitation was posted on July 28, 2026, with a response deadline of August 4, 2026, at 6:00 PM. The contract does not specify a set-aside type or funding details, and no point of contact information is provided in the data. Performance must be conducted at the Jefferson, Arkansas facility, and all work must align with the technical and operational requirements of the SafePoint system without deviation.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Annual Calibration and ISO/IEC 17025 Accredited Testing ServicesThe contract requires annual calibration of temperature probes and sensors used in laboratory refrigeration units, freezers, and incubators using NIST-traceable standards and in full compliance with ISO/IEC 17025:2017 accreditation requirements. All calibrated equipment must be labeled and accompanied by official calibration certificates to ensure traceability and regulatory adherence. The work is to be performed at the designated place of performance in Jefferson, Arkansas, with a response deadline of August 4, 2026, and is categorized as a subcontract under NAICS code 541380. The contracting activity is managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, and the solicitation was posted on July 28, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Specialized Laboratory Equipment and Consumables SupplyThe contract is for the exclusive supply of specialized laboratory equipment and consumables required for behavioral pharmacology research, including operant chambers, syringe pumps, drug formulations, solvents, and other GLP-compliant materials. This is an 8(a) Sole Source subcontract, meaning it is awarded directly to a small business certified under the SBA’s 8(a) Business Development program without competition, in accordance with FAR 19.8, to support socioeconomically disadvantaged firms. The procurement falls under NAICS code 423420, indicating it involves wholesale trade of medical, dental, and hospital equipment and supplies. The solicitation was posted on July 28, 2026, with a response deadline of August 4, 2026, and is managed by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, ensuring all delivered items meet rigorous regulatory standards for use in federal research environments.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Regulatory Science Consulting for Abuse Potential AssessmentThe contract seeks expert regulatory science consulting to provide strategic input on abuse potential assessments in alignment with FDA guidance, supporting the preparation of documentation for regulatory submissions related to drug products with potential for misuse. The scope centers on delivering scientifically sound and FDA-compliant advice to ensure regulatory pathways are met, particularly for substances requiring rigorous abuse liability evaluation as part of approval processes. This is a sole-source subcontract under the 8(a) program, designated for small disadvantaged businesses, and is assigned the NAICS code 541690 for other scientific and technical consulting services. The contracting activity is the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, with the opportunity posted on July 28, 2026, and responses due by August 4, 2026. The place of performance and point of contact details are not specified, but work is expected to be performed remotely or as mutually agreed upon, supporting federal regulatory objectives without geographic restriction.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Biostatistical Analysis and Modeling of Behavioral DataThe contract calls for advanced statistical modeling of dose-effect and demand curve data to assess the abuse liability of drug candidates and produce comparative indices that enable meaningful evaluation across multiple compounds. This work requires sophisticated biostatistical techniques to analyze behavioral data, translating raw observational and experimental results into quantifiable metrics that inform regulatory and developmental decisions regarding substance risk profiles. The models must be robust, reproducible, and aligned with current scientific standards to support objective comparisons that guide prioritization and safety assessment of pharmaceutical candidates. This is an 8(a) Sole Source subcontract under NAICS code 541690, awarded by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. The opportunity was posted on July 28, 2026, with a response deadline of August 4, 2026, indicating a tight turn-around for qualified firms to submit proposals. The work is performance-based and centers on high-level analytical capabilities, with no specified location for performance, suggesting flexibility in execution as long as deliverables meet technical requirements. The sole source designation implies the award is reserved for a small disadvantaged business certified under the 8(a) program, limiting competition to a single pre-qualified entity.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Multi-Site Study Coordination and Data HarmonizationThe contract pertains to the coordination of identical behavioral protocols across multiple research sites to ensure methodological consistency, standardized data collection, and scientific reproducibility. It is structured as an 8(a) Sole Source subcontract under NAICS code 541611, indicating it is awarded to a small business certified under the Small Business Administration's 8(a) program, with no competitive bidding process. The work is being managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, emphasizing its alignment with federal regulatory and scientific integrity goals. The contract’s primary focus is on harmonizing operational procedures and data standards to facilitate reliable multi-site research outcomes, critical for regulatory evaluation and public health applications. The solicitation was posted on July 28, 2026, with a response deadline of August 4, 2026, indicating a narrow window for proposal submission. Although specific performance locations and point of contact details are not provided, the nature of the work implies involvement across various research facilities nationally or internationally. The absence of a solicitation number and place of performance details suggests a streamlined procurement process appropriate for an 8(a) sole source award. This engagement is designed to support high-quality, standardized behavioral research output under the FDA’s oversight, ensuring that data collected from diverse sites can be aggregated, analyzed, and validated without methodological discrepancies.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Preclinical Behavioral Pharmacology TestingThe contract is for preclinical behavioral pharmacology testing aimed at evaluating the abuse liability of drugs through standardized experiments in non-human animal models. It specifically involves conducting fixed-ratio dose-effect studies and behavioral economic demand curve analyses to measure how drug availability and cost influence consumption patterns, providing critical data on reinforcement and motivational properties. These experiments follow established protocols to generate reliable, reproducible outcomes that inform regulatory assessments of drug potential for misuse. This is a subcontract under an 8(a) Sole Source acquisition, designated for small disadvantaged businesses, with the North American Industry Classification System code 541710 indicating it falls under scientific research and development services. The solicitation was posted by the FDA Office of Acquisition Grant Services within the Department of Health and Human Services, with a response deadline of August 4, 2026. The work is expected to be performed under the authority of the contracting agency, though the specific location of performance is not detailed. The contract supports federal efforts to evaluate pharmaceutical safety and inform public health policy through rigorous preclinical behavioral science.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Technical Writing and Regulatory DocumentationThe contract seeks a subcontractor to produce technical reports and regulatory documentation that summarize simulation results and the performance of AI models for submission to the FDA. The work is critical for supporting regulatory compliance and must accurately convey complex technical data in a format that meets FDA standards, ensuring all findings are clearly documented, traceable, and aligned with applicable guidelines. The deliverables will serve as foundational materials in the agency’s evaluation process for AI-driven medical technologies. The opportunity is classified under NAICS code 541690 for other scientific and technical consulting services and is issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. It is open as a subcontract with no set-aside designation, and responses are due by August 7, 2026. The place of performance and point of contact details are unspecified, but the work is expected to be completed remotely or as otherwise arranged, with the final documentation tailored to FDA requirements. Potential bidders must demonstrate expertise in technical writing for regulatory submissions and experience with AI model evaluation frameworks.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

High-Performance Computing (HPC) Infrastructure SupportThe contract seeks a subcontractor to provide and support high-performance computing infrastructure tailored for running large-scale artificial intelligence and computational fluid dynamics simulations. The work requires robust, scalable systems capable of handling intensive computational loads with minimal latency and maximum reliability, ensuring efficient execution of demanding simulation and machine learning workloads. The infrastructure must be maintained and optimized to support continuous operations, including system updates, performance monitoring, troubleshooting, and resource allocation to meet evolving project demands. The opportunity is issued under the NAICS code 541512 for custom computer programming services and is managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. The solicitation was posted on July 28, 2026, with responses due by August 7, 2026. While the place of performance and specific location details are not designated, the subcontractor is expected to deliver comprehensive HPC support services that meet the agency’s technical and operational requirements for advanced scientific computing. The contract does not specify a set-aside type or point of contact, and interested parties must refer to the official SAM.gov listing for further submission details.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE